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In Brief
The link between systemic and cellular
metabolism is a neglected aspect in
immunometabolism. Baardman et al.
show that hypercholesterolemia alters
macrophage metabolism and phenotype.
The suppressed pentose phosphate
pathway (PPP) in those ‘‘foam cell’’
macrophages attenuates inflammatory
responses, signifying that systemic and
cellular metabolism together regulate
macrophage function.
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Metabolic reprogramming has emerged as a crucial
regulator of immune cell activation, but how systemic
metabolism influences immune cell metabolism and
function remains to be investigated. To investigate
the effect of dyslipidemia on immune cell meta-
bolism, we performed in-depth transcriptional, meta-
bolic, and functional characterization of macro-
phages isolated from hypercholesterolemic mice.
Systemic metabolic changes in such mice alter
cellular macrophage metabolism and attenuate in-
flammatory macrophage responses. In addition to
diminished maximal mitochondrial respiration, hy-
percholesterolemia reduces the LPS-mediated in-
duction of the pentose phosphate pathway (PPP)
and the Nrf2-mediated oxidative stress response.
Our observation that suppression of the PPP dimin-
ishes LPS-induced cytokine secretion supports the
notion that this pathway contributes to inflammatory
macrophage responses. Overall, this study reveals
that systemic and cellular metabolism are strongly
interconnected, together dictating macrophage
phenotype and function.
INTRODUCTION
In recent years, metabolic reprogramming arose as a crucial
controller of macrophage activation (Van den Bossche et al.,2044 Cell Reports 25, 2044–2052, November 20, 2018 ª 2018 The A
This is an open access article under the CC BY-NC-ND license (http://2016, 2017). For instance, in response to pro-inflammatory
stimuli such as the Toll-like receptor 4 (TLR4) ligand lipopoly-
saccharide (LPS), macrophages show increased glycolysis, as
demonstrated by an enhanced extracellular acidification rate
(ECAR) (Van den Bossche et al., 2016). Moreover, LPS reconfig-
ures the tricarboxylic acid (TCA) cycle in macrophages and in-
duces itaconate and succinate accumulation (Jha et al., 2015;
Tannahill et al., 2013). Itaconate is a key controller of inflamma-
tory macrophage responses through its regulatory effect on
succinate dehydrogenase and its activation of the anti-oxidant
transcription factor Nrf2 (Lampropoulou et al., 2016; Michelucci
et al., 2013; Mills et al., 2018). Succinate promotes inflammation
by inducing interleukin 1b (IL-1b) expression (Mills et al., 2016;
Tannahill et al., 2013) and can activate immune cells in the local
environment upon secretion (Littlewood-Evans et al., 2016).
Furthermore, the activity of the pentose phosphate pathway
(PPP) is enhanced in LPS-stimulated macrophages, supplying
precursors for nucleotide synthesis and nicotinamide adenine
dinucleotide phosphate (NADPH), which is used for reactive ox-
ygen species (ROS) production by NADPH oxidase, fatty acid
synthesis, and anti-oxidant cellular defense (Nagy and Ha-
schemi, 2015; Wu et al., 2008). So far, most knowledge
regarding macrophage immunometabolism was obtained with
in vitro-cultured bone marrow-derived macrophages and largely
ignored the possible systemic and micro-environmental effects
on macrophage metabolism and function in vivo (Norata et al.,
2015). Exploring this neglected aspect of immunometabolism
might identify therapeutic strategies to dampen chronic inflam-
matory diseases such as atherosclerosis, in which lipid-laden
macrophage ‘‘foam cells’’ are crucial during all stages of the
disease. Elevated levels of circulating low-density lipoproteinuthors.
creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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(LDL) cholesterol, as observed in patients with familial hyper-
cholesterolemia (FH), are a prominent risk factor for developing
atherosclerosis (Ference et al., 2017). FH is predominantly
caused by loss-of-function mutations in the LDL receptor
(LDLR) gene, leading to impaired hepatic uptake of LDL and,
consequently, elevated levels of plasma LDL (Reiner, 2015). It
has been shown that hypercholesterolemia affects the lipidome
of macrophages and deactivates part of their inflammatory re-
sponses via activation of LXR (Spann et al., 2012). However,
LXR-independent repression mechanisms still need to be
defined. Here we confirm that hypercholesterolemia attenuates
LPS-induced inflammatory macrophage responses and show
that this deactivated phenotype is accompanied by a dimin-
ished Nrf2-mediated oxidative stress response and LXR-inde-
pendent suppression of the PPP, indicating that systemic and
cellular metabolism are directly intertwined, together regulating
macrophage function.
RESULTS
Hypercholesterolemia Translates into Altered Immune
Cell Metabolism
Ingenuity Pathway Analysis (IPA) of published FH patient
microarray data (GEO: GSE13985; characteristics in Table S1)
identified oxidative phosphorylation (OXPHOS) and mitochon-
drial dysfunction among the top-ranked enriched canonical
pathways (Figure 1A), and most differentially expressed genes
belonging to those pathways were downregulated in leukocytes
of FH patients (Figure 1B).
To study the effects of systemic metabolic changes on im-
mune cell metabolism in more detail, Ldlrko mice were fed
a high-fat diet (HFD) to induce hypercholesterolemia and hyper-
triglyceridemia or a normal-fat control diet (NFD) (Figures
S1A–S1C). Peritoneal macrophages from HFD mice were eli-
cited as a validated in vivo model and source of foam cells
(Spann et al., 2012). CD11b+F4/80+ peritoneal macrophages iso-
lated from the HFD group were lipid-laden foam cells (hereafter
referred to as ‘‘HFD macrophages’’; Figures S1D and S1E) and
compared with ‘‘NFD macrophages’’ to evaluate the effect of
systemic metabolism on macrophage metabolism independent
of microenvironmental cues present in atherosclerotic lesions.
To study the effects of these different lipid environments on
glycolysis and mitochondrial function in macrophages, we per-Figure 1. Hypercholesterolemia Affects Immune Cell Metabolism
(A) Top differential IPA-annotated canonical pathways between FH patients and
(B) Heatmap DEGs from the oxidative phosphorylation and mitochondrial dysfun
(C) Basal oxygen consumption rate (OCR) and ECAR of NFD and HFD macropha
(D) Oxidative phosphorylation (OXPHOS) parameters were assessed by recording
phenylhydrazone (FCCP), and rotenone plus antimycin (ROT/AA). Maximal res
Figure S2A).
(E) Dependency of NFD and HFD macrophages to oxidize glucose (pyruvate),
measured by including the inhibitors UK5099, Bis-2-(5-phenylacetamido-1,3,4-th
(F and G) Mitochondrial mass as measured by (F) MitoTracker Green staining an
(H) Measurements of respiration of isolated mitochondria.
(I) Top differential IPA-annotated pathways between NFD and HFD macrophage
(J) Heatmap of DEGs involved in cholesterol biosynthesis.
(K) Variable importance in projection (VIP) scores derived from PLS-DA to rank t
Values represent mean ± SEM of three (C and E–H) or four mice (D). *p < 0.05, *
2046 Cell Reports 25, 2044–2052, November 20, 2018formed an extracellular flux analysis and revealed similar basal
glycolysis and mitochondrial respiration in macrophages iso-
lated from mice fed either diet (Figure 1C). Interestingly, HFD
macrophages demonstrated lower maximal mitochondrial respi-
ration and a reduced spare respiratory capacity (SRC) (Figure 1D)
but showed no differences in non-mitochondrial oxygen con-
sumption, ATP production, and proton leak (Figure S2A).
Furthermore, both macrophage types showed similar fuel de-
pendencies, with fatty acids being the main drivers of mitochon-
drial oxygen consumption (Figure 1E).
Because reduced mitochondrial mass results in decreased
SRC in T cells (van der Windt et al., 2012), we assessed whether
a lower mitochondrial abundance could explain the reduced
SRC in HFD macrophages. Supporting this notion, HFD macro-
phages indeed showed a lower mitochondrial mass, as demon-
strated by MitoTracker Green staining, mitochondrial DNA:ge-
nomic DNA ratio, and mitochondrial complex immunoblotting
(Figures 1F and 1G and S2B). Together with the observation
that similar amounts of mitochondria isolated from NFD or HFD
macrophages display equal respiration (Figure 1H), our data
strongly suggest that the reduced maximal respiration in HFD
macrophages is mainly due to a decrease in mitochondrial
mass. RNA sequencing revealed that genes related tomitochon-
drial biogenesis and dynamics were not altered in HFD macro-
phages; this was further confirmed by qPCR and immunoblotting
(Figures S2C–S2E). Pathway analysis indicated that the topmost
enriched pathways were related to cholesterol biosynthesis, and
associated genes were downregulated in HFD macrophages
(Figures 1I and 1J).
Given the importance of metabolites such as itaconate, succi-
nate, and a-ketoglutarate in regulating macrophage function
(Lampropoulou et al., 2016; Liu et al., 2017; Michelucci et al.,
2013; Mills et al., 2016, 2018; Tannahill et al., 2013), we next
measured the levels of an extensive set of 63 metabolites. Partial
least square discriminant (PLS-DA) analysis was used to
discriminate NFD and HFD macrophages based on the
measured metabolites. Interestingly, the abundance of several
metabolites varied among NFD and HFD macrophages, with
itaconate as the most distinctive metabolite (Figure 1K), whose
abundance was lower in HFD macrophages (Table S2). Overall,
hypercholesterolemia is associated with reduced mitochondrial
mass and maximal respiration and affects the levels of metabo-
lites such as itaconate.controls based on their differentially expressed genes (DEGs).
ction pathways.
ges.
OCR after injection of oligomycin (OM), carbonyl cyanide-4-(trifluoromethoxy)
piration and spare respiratory capacity were plotted in bar graphs (see also
glutamine (glutamate), and fatty acids to fuel mitochondrial respiration, as
iadiazol-2-yl)ethyl sulfide (BPTES), and etomoxir, respectively.
d (G) mtDNA:genomic DNA (gDNA) ratio (see also Figure S2B).
s based on DEGs.
he measured metabolites on their contribution to the model.
*p < 0.01 by two-tailed Student’s t test.
Hypercholesterolemia Attenuates Inflammatory
Macrophage Responses without Major Changes in
Glycolysis or the TCA Cycle
Because itaconate regulates inflammatory macrophage re-
sponses (Jha et al., 2015; Mills et al., 2018) and was reduced
in naive HFDmacrophages, we investigated the effects of hyper-
cholesterolemia on LPS-induced inflammatory macrophage
activation. In parallel to the previously reported decreased
expression of several inflammatory genes, we identified reduced
secretion of pro-inflammatory cytokines as well as lower nitric
oxide (NO) and lower ROS levels in HFD macrophages (Figures
2A–2C). Both types of macrophages exhibited similar phago-
cytic activity and comparable expression of Il10 and IL-4-
induced genes and surface proteins (Figures 2D, S3A, and
S3B). Together, this does not indicate a general inhibition of
macrophage activation in the HFD group but shows that these
cells undergo a deactivation process during which foam cells
lose part of their LPS-induced inflammatory properties. Like-
wise, short exposure to oxidized or acetylated LDL in vitro also
decreased subsequent LPS-induced tumor necrosis factor
(TNF), IL-6, and NO secretion in NFDmacrophages (Figure S3C).
To address whether distinct LPS-induced metabolic rewiring
underlies the deactivated phenotype of HFD foam cells, we
measured glycolysis upon acute and 24-hr LPS exposure. NFD
and HFD macrophages showed comparable glycolytic rates
and glucose uptake (Figure 2E, 2F, and S3D), indicating that
the attenuated inflammatory phenotype of HFD macrophages
is probably not caused by reduced glycolysis.
Next we examined whether differences in succinate, itaco-
nate, a-ketoglutarate, or other metabolites could explain the
attenuated pro-inflammatory function of LPS-stimulated HFD
macrophages. PLS-DA identified distinct metabolic profiles
upon LPS stimulation in macrophages from both groups (Fig-
ure 2G). We observed that LPS induced itaconate, succinate,
and oxaloacetate levels to a similar extent in both NFD and
HFD macrophages (Figure 2H). This suggests that the reduced
inflammatory phenotype observed in HFD macrophages is not
caused by a distinct LPS-induced TCA cycle reconfiguration.
In addition to altered levels of different amino acids (Figures 2I)
and increased levels of NADH in HFD macrophages (Table S2),
several metabolites related to the PPP (marked with asterisks
in Figure 2I) strongly contributed to the differential metabolic pro-
file in LPS-stimulated NFD and HFD macrophages.
Hypercholesterolemia Diminishes the NRF2 and PPP in
Macrophages
Metabolic analysis demonstrated an increased abundance of
several PPP metabolites, including ribose-5P or ribulose-5P, se-
doheptulose-7P, and glyceraldehyde 3-P upon LPS stimulation
(Figure 3A). Interestingly, LPS-induced ribose-5P or ribulose-
5P and sedoheptulose-7P levels were lower in HFD macro-
phages. Analyzing the two genes that encode glucose-6-phos-
phate dehydrogenase (G6PD) as the rate-limiting enzyme of
the PPP in mice (Huminiecki and Wolfe, 2004) revealed that the
LPS-induced elevation of G6pd2, but not G6pdx, was absent
in HFD macrophages (Figures 3B and 3C). Moreover, Pgd (en-
coding 6-phosphogluconate dehydrogenase, which converts
6-phosphogluconate into ribulose 5-P in the PPP) was reducedin both naive and LPS-stimulated HFDmacrophages (Figure 3B),
whereas Pgd protein levels were only suppressed in naive HFD
macrophages (Figure S4A). To validate whether suppression
of the PPP in HFD macrophages (Figure 3D) could explain
their attenuated LPS-induced inflammatory responses, we
pharmacologically inhibited G6PDwith dehydroepiandrosterone
(DHEA) or 6-aminonicotinamide (6-AN). Supporting this notion,
blockade of the PPP diminished the LPS-induced production
of pro-inflammatory mediators in macrophages (Figure 3E).
Because desmosterol-driven LXR activation regulates at least
a part of the inflammatory phenotype of foam cells (Spann
et al., 2012), we studied whether this pathway controls the
PPP. Activation of LXR and its target genes with GW3965 did
not affect PPP genes and metabolites (Figures S4B–S4D),
backing the idea that both LXR-dependent and independent
mechanisms contribute to the diminished inflammatory pheno-
type of foam cells (Spann et al., 2012).
To uncover theLXR-independentmechanistic linkbetweenhy-
percholesterolemia, suppressed PPP, and inflammation, we
further explored our RNA sequencing (RNA-seq) dataset. Path-
ways analysis revealed that theNrf2 pathwaywas themost differ-
entially regulated pathway between LPS-stimulated NFD and
HFD macrophages (Figure 3F), and most genes of this pathway
were downregulated in HFD macrophages (Figure 3G). Accord-
ingly, Nrf2 protein levels were reduced in LPS-treated HFDmac-
rophages (Figure 3H). Importantly, Nrf2 was found to be a regu-
lator of the PPP in cancer cells (Mitsuishi et al., 2012) and
analyzing expression data from Nrf2-deficient macrophages
(GEO: GSE71695) revealed that several PPP genes, including
Pgd, are downregulated in Nrf2-deficient macrophages (Fig-
ureS4E).Moreover, analysis of published chromatin immunopre-
cipitation (ChIP-seq) data (DDBJ: DRA003771) revealed binding
of Nrf2 4 kb upstream of the Pgd locus (Figure 3I), suggesting a
direct link between reduced Nrf2 activity and Pgd expression in
HFD macrophages. Indeed, Pgd is suppressed in Nrf2-deficient
macrophages and increased in macrophages that have lower
levels of the Nrf2 repressor protein KEAP1 (Figure 3J). Accord-
ingly, the LPS-induced production of sedoheptulose-7P and
ribose-5P or ribulose-5P downstream of Pgd in the PPP was
blunted in the absence of Nrf2 (Figure S4F). This suppressed
Nrf2 signaling acts in parallel with other pathways, like the LXR
pathway (Spann et al., 2012), and manipulating one branch
does not recapitulate the deactivated phenotype observed in
HFD macrophages. Indeed, Nrf2-deficient macrophages did
not show overall suppressed LPS responses (Figure S4G).
Together, this demonstrates a link between reduced Nrf2 and
a defective PPP in HFDmacrophages and that the latter pathway
supports inflammatory responses.
DISCUSSION
Recent findings in the rapidly expanding field of immunometab-
olism underscored the importance of metabolic reprogramming
during macrophage activation (Van den Bossche et al., 2017).
However, most knowledge regarding this metabolic-immuno-
logic crosstalk has emerged from in vitro-culturedmacrophages,
excluding different (e.g., microenvironmental and systemic)
layers of regulation that are at play in vivo. This gave us theCell Reports 25, 2044–2052, November 20, 2018 2047
Figure 2. Hypercholesterolemia Attenuates the Inflammatory Phenotype of Macrophages without Reconfiguring Glycolysis and the TCA
Cycle
(A) Selected inflammatory genes in LPS-stimulated NFD and HFD macrophages (IL-4 response in Figures S3A and S3B).
(B) Cytokine and NO production by NFD and HFD macrophages (see also Figure S3C).
(C) Reactive oxygen species (ROS) levels as measured with 5-(and-6)-chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA).
(D) Phagocytic capacity (see also Figure S3E).
(E) Real-time ECAR of NFD and HFD macrophages. The bar graph represents the acute LPS-induced ECAR.
(F) Glycolysis parameters were determined by recording the ECAR after injection of glucose, OM, and 2-deoxyglucose (2-DG). The glycolytic rate is plotted in a
bar graph (glucose uptake in Figure S3D).
(G) PLS-DA plotted discrimination between LPS-stimulated NFD and HFD macrophages based on LC–HRMS analysis of 63 metabolites.
(H) Relative abundance of TCA cycle intermediates as measured by liquid chromatography-high resolution mass spectrometry (LC-HRMS).
(I) VIP scores derived from PLS-DA based on LPS-stimulated NFD and HFD macrophages to rank metabolites on their contribution to the model. Pentose
phosphate pathway (PPP) metabolites are marked with asterisks.
Values represent mean ± SEM of three (B–F) or four mice (H). One-way ANOVA; *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 3. Hypercholesterolemia Reduces LPS-Mediated Induction of the PPP in Macrophages
(A) Relative abundance of PPP metabolites.
(B) Expression levels of genes encoding PPP enzymes represented as RPKM (reads per kilobase per million mapped reads). Horizontal lines represent mean
values.
(C) G6pdx and G6pd2 gene expression.
(D) Schematic representation of the abundance and expression of PPP metabolites and genes.
(E) Cytokine and NO production by macrophages in the absence or presence of LPS and 100 mM G6PD inhibitor dehydroepiandrosterone (DHEA) or 6-ami-
nonicotinamide (6-AN).
(legend continued on next page)
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incentive to explore the influences of different systemic lipid en-
vironments on cellular macrophage metabolism and function.
Leukocytes from FH patients demonstrated reduced expres-
sion of genes related to OXPHOS. In mice, hypercholesterolemia
was associated with reduced cholesterol biosynthesis in macro-
phages. Differences in cell type (total leukocytes versus macro-
phages) or species (human versus mouse) might underlie this
discrepancy. Dhcr24, which encodes 24-dehydrocholesterol
reductase, which converts desmosterol into cholesterol, was
the most suppressed gene related to cholesterol biosynthesis
in macrophages from HFD mice. This finding is in agreement
with a previous study, and diminished Dhcr24 expression was
found to result in the accumulation of desmosterol in HFD mac-
rophages (Spann et al., 2012).
Isolated macrophages from hypercholesterolemic mice
showed reduced maximal respiration and SRC. In T cells, SRC
is positively correlated with their survival (van der Windt et al.,
2012). Therefore, decreased SRCmight increase the susceptibly
to apoptosis in macrophage foam cells, potentially contributing
to necrotic core development in atherosclerotic lesions (Moore
et al., 2013).
It is well-accepted that atherosclerosis is a chronic inflamma-
tory disease driven by elevated LDL cholesterol levels. The
Canakinumab Antiinflammatory Thrombosis Outcome Study
(CANTOS) trial provides strong evidence in support of the inflam-
mation hypothesis and demonstrated that neutralizing the pro-
inflammatory cytokine IL-1b significantly reduces the rate of
recurrent cardiovascular events (Ridker et al., 2017).
Confirming previous literature (Spann et al., 2012), we now
observed that the LPS-induced secretion of inflammatory medi-
ators was reduced in macrophages isolated from hypercholes-
terolemic mice. This might appear to be inconsistent with the
inflammation hypothesis of atherogenesis. However, it is impor-
tant to note that both in vivo-elicited HFD foam cells and in vitro
LDL-exposed macrophages still produce considerable amounts
of inflammatory cytokines upon activation, albeit to a lower
extend than ‘‘normal’’ macrophages. Another explanation for
the observed deactivated phenotype of foam cells could be the
phenotypic diversity detected in plaques (Cochain et al., 2018).
Not all plaque macrophages exhibit a pro-inflammatory pheno-
type, and there is a substantial subpopulation of macrophages
with anti-inflammatory features (Kadl et al., 2010). In agreement
with our observations, recent transcriptome analysis of macro-
phages from atherosclerotic aortae revealed that lipid-loaded
plaquemacrophages are less inflammatory than their non-foamy
counterparts (Kimet al., 2018).We therefore favor the theory that,
in addition to the systemicmetabolic environment,microenviron-
mental cues regulatemacrophagephenotypes inplaques (Spann
et al., 2012) to promote the chronic inflammatory responses that
are demonstrably driving atherogenesis.
Accumulation of cellular cholesterol leads to specific oxyster-
ols and sterols that regulate the activity of LXR (Spann et al.,(F) Top differential IPA-annotated pathways between LPS-stimulated NFD and H
(G) Heatmap of DEGs from the ‘‘NRF2-mediated oxidative stress response’’ IPA
(H–J) NRF2 immunoblot (H), ChIP-seq binding profile of Nrf2 at the Pgd locus in m
Values represent mean ± SEM of three (C, E, and J) or four mice (A). One-way A
2050 Cell Reports 25, 2044–2052, November 20, 20182012). LXRs bind to and prevent the removal of repressor com-
plexes at TLR4-responsive genes, blunting their expression and
exerting anti-inflammatory effects (Ghisletti et al., 2007). We now
show that, in addition to LXR (Spann et al., 2012), LXR-indepen-
dent impairment of the PPP contributes to the suppressed
inflammatory responses in macrophage foam cells during
hypercholesterolemia.
Interestingly, we discovered that 6-phosphogluconate dehy-
drogenase (Pgd) gene expression and downstream metabolites
were blunted inHFDmacrophages. In accordance, knockdown of
PGD was found to reduce the oxidative PPP flux, NADPH:NADP+
ratio, and ribulose-5P and ribose-5P levels in human cancer cells
(Lin et al., 2015). NADPH and ribose-5P generated in the PPP can
support the inflammatory macrophage responses in different
ways, including ROS production, anti-oxidant cellular defense,
fatty acid synthesis, and nucleotide production (Nagy and Ha-
schemi, 2015). Thus, reduced flux through the PPP as observed
in HFD macrophages can cause attenuated inflammatory re-
sponses and ROS production. Furthermore, Pgd expression was
already reduced in naive HFD macrophages, possibly creating a
condition that causes impaired future LPS responses. Vice versa,
the lower PPP might also be a consequence of an attenuated in-
flammatory phenotype in HFDmacrophages and the consecutive
lower demand for PPP-derived products that regulate inflamma-
tion and anti-oxidant cellular defense.
We identified the Nrf2-mediated oxidative stress response as
the most suppressed pathway in LPS-stimulated HFD macro-
phages. Nrf2 emerged as a crucial regulator of the inflammatory
responses in macrophages (Kobayashi et al., 2016; Mills et al.,
2018). Interestingly, several PPP genes were previously identi-
fied as Nrf2 target genes in cancer cells (Mitsuishi et al., 2012).
Here we emphasized the importance of the Nrf2 pathway in
the regulation of the PPP in macrophages. Importantly, sup-
pressed Nrf2 is not the only mediator of the HFD macrophage
phenotype and probably acts in parallel with other mechanisms,
like the desmosterol-induced LXR pathway that was described
earlier (Spann et al., 2012). Indeed, LXR activation or Nrf2 dele-
tion as such did not result in the deactivated HFD macrophage
phenotype. Our observations agree with previous studies
demonstrating normal IL-1b, TNF, and IL-6 expression in the
absence of Nrf2 (Mills et al., 2018; Bambouskova et al., 2018;
Kobayashi et al., 2016). Conversely, activation of Nrf2 in macro-
phages by pharmacological or genetic (low KEAP1 expression)
means clearly dampens inflammatory responses (Kobayashi
et al., 2016) and mediates the anti-inflammatory effects of the
metabolite itaconate (Mills et al., 2018). Thus, low levels of Nrf2
do not affect LPS responses as such, but Nrf2 activation is
clearly anti-inflammatory. It will be of interest to define the mech-
anism responsible for Nrf2 repression in macrophage foam cells.
Together, these observations show that hypercholesterolemia
suppresses the Nrf2 and PPP in macrophages and deactivates
their inflammatory phenotype. We demonstrate that systemicFD based on DEGs.
canonical pathway.
acrophages (I), and Pgd expression (J) (see also Figures S4A and S4E–S4G).
NOVA; *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.
metabolic changes translate into rewired intracellular metabolic
pathways in macrophages that are tailored to support their
effector functions. This highlights the intricate interplay between
inflammatory signaling and metabolic pathways.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Female and male LdlrKO mice were obtained from Jackson Laboratory. LdlrKO mice were housed at the Animal Research Institute
AMC (ARIA) and all animal experiments were conducted after approval (permit: DBC102861) by the Committee for Animal Welfare
of the Academic Medical Center, University of Amsterdam. 6-month old adult mice were used for experiments and put on a control
normal fat diet (NFD, 4% fat, Harlan Laboratories) or a high fat, high cholesterol diet (HFD, 16% fat, 0,25% cholesterol, Special Diet
Services) for 10 weeks. Nrf2-knockout (Nrf2KO) (Itoh et al., 1997) and Keap1-knockdown (Keap1KD) (Taguchi et al., 2010) mice, and
their wild-type (WT) counterparts, all 8-12-week old females on the C57BL/6 genetic background, were bred and maintained in the
Medical School Resource Unit of the University of Dundee. Mice of the same sex were randomly assigned to both experimental
groups in disposable Innovive 101 IVC cages in groups of 3 or 4.
METHOD DETAILS
Isolation of macrophages
After 10 weeks of NFD or HFD, LldrKO mice were euthanized by CO2 asphyxiation. Four days prior to sacrifice, mice were intraper-
itoneally injected with 3% thioglycollate medium (Fisher Scientific). Upon sacrifice, the peritoneum was flushed with 10 mL ice-cold
PBS and collected peritoneal cells were cultured in RPMI-1640 containing 25 mM HEPES, 2 mM L-glutamine, 10% FCS, 100 U/ml
penicillin and 100 mg/ml streptomycin (GIBCO). After 3 h, non-adherent cells were washed away and adhered cells (typically consist-
ing of 90%–95%CD11b+ F4/80+macrophages, Figure S1D) were stimulated for 24 hours with 10 ng/ml LPS (Sigma) or 100 U/ml IL-4
(Peprotech), or were left untreated, and were used for further analyses. Blood cholesterol and triglyceride levels were measured by
enzymatic methods using available kits (Roche). To determine lipid accumulated in peritoneal macrophages, tissue slides with cells
were fixed in 4% formalin for 10 minutes and washed two times with PBS (with magnesium and chloride) before and after fixation.
Subsequently, tissue slides were incubated in 60% isopropanol for 15 minutes before staining for 45 minutes with fresh 0.3%Oil Red
O in 60% isopropanol. After staining, tissue slides were rinsed in 60% isopropanol, washed in distilled water, incubated for 1 minute
with hematoxylin blued in tap water and rinsed with distilled water. Bone-marrow derived (BMDM) macrophages were generated
from femurs and tibia fromWT, Nrf2KO and Keap1KD mice and differentiated in RPMI-1640 containing 25 mMHEPES, 2 mM L-gluta-
mine, 10% FCS, 100 U/ml penicillin and 100 mg/ml streptomycin and 15% L929-conditioned medium for 7 days.
Metabolic extracellular flux analysis
Macrophages (1x105 cells/well) were plated on XF-96-cell culture plates (Seahorse Bioscience) and treated as specified. OCR and
ECAR were assessed using the XF-96 Flux Analyzer (Seahorse Bioscience) as detailed before (Van den Bossche et al., 2015).
Changes in ECAR in response to glucose (10 mM), OM (1.5 mM) and 2-DG (100 mM) injection were used to calculate all glycolysis
parameters and OXPHOS characteristics were calculated from the OCR changes in response to OM (1.5 mM), FCCP (1.5 mM) and
rotenone (1.25 mM) + antimycin A (2.5 mM) injection (Van den Bossche et al., 2015; Van den Bossche et al., 2016). The Seahorse
Bioscience Mito Fuel Flex Test Kit was used to determine the dependency of cells for glucose, glutamine or fatty acid oxidation.
Respiratory measurements of isolated mitochondria
To isolate mitochondria, cell pellets were resuspended in 1 mL of MTE buffer (250 mMmannitol, 5 mM TRIS, 0.5 mM EDTA, pH 7.4).
Macrophages were lysed using 10 passages through the cell cracker (European Molecular Biology Laboratory, Heidelberg,
Germany). The homogenate was centrifuged 10 min at 1000 g, after which the supernatant was transferred to a new tube and centri-
fuged at 10000 g. The resulting supernatant was considered the cytosolic fraction. The final pellet containing the mitochondrial frac-
tion was washed with 1 mLMTE buffer, centrifuged at 3600 g and resuspended in a minimal volume of MTE buffer. Equal amounts of
mitochondria (0.5 mg well) were resuspended in MAS buffer (70 mM sucrose, 220mMmannitol, 10 mMKH2PO4, 5 mMMgCl2, 2 mM
HEPES, and 1 mM EGTA; pH 7.2, plus 10 mM pyruvate and 1 mM malate as substrates), transferred to XF-96-cell culture plates,
centrifuged at 2000 g for 20 min at 4C and measured using a XF-96 Flux Analyzer (Seahorse Bioscience) to assess basal oxygen
consumption (state 2), maximal coupled respiration or state 3 after injection of 4 mM ADP, state 4o after injection of 1.5 mM OM,
maximal uncoupled respiration (state 3u) after injection of 4 mM FCCP and the respiratory control ratio (RCR = state 3/state 4o) in
accordance to an established protocol (Rogers et al., 2011).
Liquid chromatography - mass spectrometry
Macrophages (5x105 cells/well) in 24 well plates were washed three times with 0,9% NaCl. Metabolism was quenched by adding
1 mL ice-cold methanol/water (1/1; v/v). The following internal standards were added, D3-aspartic acid, D3-serine, D5-glutamine,Cell Reports 25, 2044–2052.e1–e5, November 20, 2018 e3
D3-glutamate,
13C3-pyruvate,
13C6-isoleucine,
13C6-glucose,
13C6-fructose-1,6-biphosphate,
13C6-glucose-6-phosphate, adenosi-
ne-15N5-monophosphate and guanosine-
15N5-monophosphate (5 mM). 1 mL of chloroform was added, vortexed and centrifuged
for 5 minutes at 14.000 rpm at 4C. 800 mL of the ‘‘polar’’ top layer was transferred to a 1.5 mL tube, dried to dryness in a vacuum
concentrator and dissolved in 100 mL methanol/water (6/4; v/v). For the analysis, we used a Thermo Scientific (U)HPLC system
coupled to a Thermo Q Exactive (Plus) Orbitrap mass spectrometer (Waltman) with a SeQuant ZIC-cHILIC column at 15C (PEEK
1003 2.1 mm, 3.0 mmparticle size, Merck). The mobile phase composed of (A) 9/1 acetonitrile/water with 5 mM ammonium acetate;
pH 6.8 and (B) 1/9 acetonitrile/water with 5 mM ammonium acetate; pH 6.8, respectively. The LC program started with 100% (A) hold
0-3 min; ramping 3-24 min to 20% (A); hold from 24-27 min at 20% (A); ramping from 27-28 min to 100% (A); and re-equilibrate from
28-35 min with 100% (A), flow rate was 0.250 mL/min. The MS data were acquired in full scan, negative ionization mode with a mass
resolution of 140.000. Interpretation of the data was performed in the Xcalibur software (ThermoFisher). Subsequent analyses were
done in a R environment using the ggplot2, ropls andmixOmics packages (Rohart et al., 2017; The´venot et al., 2015;Wickham, 2016).
Flow cytometry
To assess surfacemarker expression, cells (1.5x105 cells/well) in 96 well plates were deateched with citrate and transferred to V-bot-
tom 96 well plates and stained with CD71, CD206, CD273, CD301 or isotype controls (all 1:250 diluted in PBS with 0,5% BSA and
2.5mMEDTA) for 20minutes at room temperature in the dark. After labeling, cells were washedwith PBSwith 0,5%BSA and 2.5mM
EDTA and finally resuspend in PBS with 0,5%BSA and 2.5 mM EDTA andmeasured on BD FACSCanto or a Beckman Coulter Cyto-
FLEX, and analyzed using FlowJo (TreeStar). In order to quantify mitochondrial mass and ROS production, macrophages (105 cells/
well) in 96 well plates were detached using citrate buffer (17 mM tri-Sodium citrate dehydrate and 135 mM potassium chloride in wa-
ter) transferred to V-bottom 96 well plates and washed with PBS. Next, cells were resuspended in PBS with 200 nm MitoTracker
Green or 20 mM CM-H2DCFDA (both ThermoFisher) and incubated for 30 minutes at 37
C (5% CO2). After incubation, cells were
washed with PBS and mitochondrial mass and ROS production was measured using flow cytometry. To determine glucose uptake,
macrophages (105 cells/well) were cultured in 96 well plates for two hours in RPMI-1640 lacking glucose and serum. Subsequently,
2-NBDG (ThermoFisher) was added for an additional incubation of 20 minutes in a final concentration of 25 mM. Next, cells were
detached with citrate buffer, transferred to V-bottom 96 well plates and washed with PBS and analyzed using flow cytometry.
To assess phagocytic activity, 105 macrophages were cultured for 1 h at 37C (or 4C as a control, Figure S3E) in the presence of
Fluoresbrite YG microspheres (0.5 mM, Polysciences).
Immunoblotting
Immunoblotting for NRF2 and mitochondrial complexes was performed as detailed by (Mills et al., 2018) and (W€ust et al., 2016),
respectively. For MFN1, MFN2, OPA1 and PGD immunoblotting, macrophages (1x106 cells/well) in 12 well plates were lysed in
NP40 cell lysis buffer (ThermoFisher) supplemented with protease inhibitor cocktail (Sigma-Aldrich) and PhosSTOP (Sigma-Aldrich).
Lysates were equalized on protein concentration after quantification with the BCA assay (ThermoFisher), separated on Bolt 4%–12%
Bis-Tris gels (ThermoFisher) and transferred onto nitrocellulose membranes (Bio-Rad). After blocking for 1 hour with 5%milk powder
(Campina) in Tris-buffered saline, TWEEN 20 (TBS-T), membranes were incubated overnight with primary antibodies against MFN1
(1:1000 dilution), MFN2 (1:200), OPA1 (1:1000) and PGD (1:1000) in 5% milk, TBS-T, followed by incubation for 1 hour with horse-
radish peroxidase (HRP)-conjugated secondary antibodies (1:2000) in 5% milk, TBS-T and visualization with SuperSignal West
Pico Chemiluminescent PLUS Substrate (Thermo Fisher Scientific).
Cytokine and NO production
IL-6 and TNF levels in the supernatant were measured by ELISA (Life Technologies) and NO production was assessed by a Griess
reaction (Sigma-Aldrich) according to the supplier’s protocol.
RNA sequencing
Total RNA was isolated from peritoneal macrophages using a RNeasy Mini Kit with DNase treatment (QIAGEN). Strand-specific
libraries were constructed from 100 ng total RNA using ‘Ovation RNA-Seq system’ following manufacturer instructions (NuGen
Technologies). Samples were pooled and diluted to 10 nM and sequenced on an Illumina HiSeq 4000 instrument (Illumina) to a depth
of ± 20 million single-ended 50 bp reads.
Bioinformatics
Reads were aligned to the mouse genome mm10 by STAR 2.5.2b with default settings (Dobin et al., 2013). BAM files were indexed
and filtered on MAPQ > 15 with SAMTools 1.3.1 (Li et al., 2009). Raw tag counts and RPKM (reads per kilobase per million mapped
reads) values per gene were summed using HOMER20s analyzeRepeats.pl script with default settings and the -noadj or –rpkm op-
tions for raw counts and RPKM reporting, respectively (Heinz et al., 2010). Differential expression was assessed using the DESeq2
bioconductor package in an R 3.3.1 environment with gene expression called differential with a p value < 0.05 and an average
RPKM > 1 in at least one group (Love et al., 2014). Presented RPKM values in scatterplots were tested using one-way ANOVA fol-
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was executed using the limma package and gene expression was called differential with a p value < 0.05 (Ritchie et al., 2015). Dif-
ferential expressed genes were analyzed in Ingenuity Pathway Analysis (Qiaqen) to identify deregulated pathways.
qPCR
RNAwas isolated with High Pure RNA Isolation kits (Roche), cDNAwas synthesized with iScript (Bio-Rad), and qPCRwas performed
using SYBRGreen Fast mix (Applied Biosytems) on a ViiA7 (Applied Biosystems). Housekeeping genesRplp0 andPpiawere used for
normalization and used primer sequences are noted in the Table S3. DNA was extracted using the Quick-gDNA MiniPrep (Zymo
Research) kit and primers for mt-Co1 and Ndufv1 were used to determine the mtDNA/gDNA ratio.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data are presented as mean ± standard error of the mean (SEM). Number (n) and type (biological or technical) of replicates are
indicated in the figure legends. Data were tested using a two-tailed Student’s t test (when comparing two groups) or one-way
ANOVA followed by Bonferroni’s post hoc comparison to test multiple groups in GraphPad Prism version 7.0 software, as indicated
in the figure legends. p values < 0.05 were considered significant, with levels of significance being indicated as follows: *p < 0.05;
**p < 0.01; ***p < 0.001; ns, not significant.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA sequencing data reported in this paper is GEO: GSE107412.Cell Reports 25, 2044–2052.e1–e5, November 20, 2018 e5
